HR 6977
Better Care for PFAS Patients Act of 2026
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 4:12 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill aims to improve healthcare for individuals potentially affected by per- and polyfluoroalkyl substances (PFAS). It requires the Agency for Toxic Substances and Disease Registry to partner with a scientific organization to regularly assess the health effects of PFAS, develop clinical recommendations, and provide updated guidance to healthcare providers and public health officials. The goal is to ensure that medical professionals have the most current information to diagnose and treat PFAS-related illnesses. This legislation seeks to enhance patient care and public health response to PFAS exposure.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.